Analysts Set Danaher Corporation (NYSE:DHR) PT at $245.91

Shares of Danaher Corporation (NYSE:DHR) have earned an average rating of “Moderate Buy” from the twenty-one research firms that are covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $245.9130.

Several equities analysts have recently issued reports on DHR shares. Evercore ISI cut their price objective on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a report on Friday, July 11th. Barclays reiterated an “overweight” rating and issued a $225.00 price target (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a report on Saturday, September 27th.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Institutional Investors Weigh In On Danaher

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Danaher by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after purchasing an additional 788,499 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Danaher by 3.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 19,592,211 shares of the conglomerate’s stock worth $4,016,404,000 after purchasing an additional 612,154 shares in the last quarter. Geode Capital Management LLC boosted its position in Danaher by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 13,726,194 shares of the conglomerate’s stock worth $2,697,800,000 after purchasing an additional 81,670 shares in the last quarter. Norges Bank purchased a new stake in Danaher in the 2nd quarter worth approximately $1,979,503,000. Finally, Bank of New York Mellon Corp boosted its position in Danaher by 2.3% in the 1st quarter. Bank of New York Mellon Corp now owns 8,783,485 shares of the conglomerate’s stock worth $1,800,614,000 after purchasing an additional 194,466 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

DHR opened at $211.65 on Tuesday. Danaher has a 52-week low of $171.00 and a 52-week high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a market cap of $151.55 billion, a P/E ratio of 45.03, a price-to-earnings-growth ratio of 3.06 and a beta of 0.77. The firm’s 50-day moving average price is $200.36 and its 200-day moving average price is $197.24.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the company posted $1.72 earnings per share. The company’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts anticipate that Danaher will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.